<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03623893</url>
  </required_header>
  <id_info>
    <org_study_id>2017.596</org_study_id>
    <secondary_id>852001903</secondary_id>
    <nct_id>NCT03623893</nct_id>
  </id_info>
  <brief_title>Hernia Exploration oR Not In Infants Analysis</brief_title>
  <acronym>HERNIIA</acronym>
  <official_title>A Randomized Controlled Trial to Study the Effectiveness and Cost-effectiveness of Contralateral Surgical Exploration During Unilateral Inguinal Hernia Repair in Children.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VU University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VU University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effectiveness and cost-effectiveness of contralateral surgical
      exploration during unilateral inguinal hernia repair in children younger than six months with
      a unilateral inguinal hernia. In half of the participants contralateral exploration will be
      performed, while in the other half only unilateral inguinal hernia repair will be performed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is a high incidence of metachronous (i.e. a second) contralateral inguinal hernia
      (MCIH) in infants with an inguinal hernia (5-30%, most studies report 10%), with the highest
      risk in infants aged less than 6 months. Metachronous hernia is associated with the risk of
      incarceration and general risks and costs of a second operation. This can potentially be
      avoided by contralateral exploration at the first operation. On the other hand contralateral
      exploration may turn out to be unnecessary, is associated with additional operating time and
      cost, and may be associated with additional complications of surgery (including testicular
      atrophy, wound infection) and anesthesia. Both policies to routinely explore the
      contralateral side or not are used in the treatment of unilateral inguinal hernias in
      children. There is no high-grade level of evidence of the superiority of one of either
      policy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 17, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Multicenter randomized controlled trial.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Participants and care providers are aware of allocation; masking is impossible because of the nature of the intervention.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of infants that undergo a second operation</measure>
    <time_frame>One year after primary hernia repair</time_frame>
    <description>The number of infants that undergo a second operation related to unilateral inguinal hernia within one year after primary inguinal hernia repair</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total duration of operation(s) including anaesthesia time and hospital admission(s)</measure>
    <time_frame>One year after primary hernia repair</time_frame>
    <description>Total duration of operation(s) including anaesthesia time and total duration of hospital admission(s) related to inguinal hernia within one year after primary repair</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications of anaesthesia and surgery</measure>
    <time_frame>During hospital admission, four weeks and one year after primary hernia repair</time_frame>
    <description>Occurence of wound infection, hematoma, hydrocele, testicular atrophy, apnoea or recurrence of inguinal hernia, related to hernia repair.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life (HRQOL) of the operated infant</measure>
    <time_frame>At baseline before surgery, 4 weeks and one year after primary hernia repair and, if relevant, four weeks after re-operation</time_frame>
    <description>HRQOL of the operated infants is measured by the TAPQOL (TNO-AZL Preschool Children Quality of Life), a parent-reported questionnaire that is clustered into 12 multi-item scales, with higher scores (range 0-100) indicating better HRQOL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parental distress and anxiety</measure>
    <time_frame>At baseline before surgery, 4 weeks and one year after primary hernia repair and, if relevant, before and four weeks after re-operation</time_frame>
    <description>Parental distress and anxiety of the families of the operated infants is measured by 1) State-Trait Anxiety Inventory (STAI), used as an indicator of parental distress, and 2) Distress Thermometer for Parents (DT-P), a well-validated, brief screening instrument that is frequently used in clinical practice in the Netherlands as a quick screener to identify distress and everyday problems in parents of children who need medical treatment.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Economic evaluation</measure>
    <time_frame>Four weeks and one year after primary hernia repair and, if relevant, four weeks after re-operation</time_frame>
    <description>Total health care costs associated with each strategy, assessed by a retrospective cost questionnaire and the iMTA Productivity Cost Questionnaire (iPCQ).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">378</enrollment>
  <condition>Inguinal Hernia</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Unilateral inguinal hernia repair with contralateral exploration.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Unilateral inguinal hernia repair.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Contralateral exploration</intervention_name>
    <description>Surgery eventually performed when a patent processus vaginalis or hernia exists on the other side than the side on which the child has to be operated on, will be exactly the same as the inguinal hernia repair on the 'symptomatic' side. Exploration of the contralateral side will increase anaesthesia time by 10-15 minutes.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Infants aged younger than six months at first presentation with a primary unilateral
        inguinal hernia undergoing open hernia repair are considered eligible for inclusion.

        Exclusion Criteria:

        Infants with (1) incarcerated inguinal hernia requiring urgent surgery, (2) a
        ventricular-peritoneal drain, (3) non-descended testis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kelly Dreuning, MD</last_name>
    <phone>+31613438132</phone>
    <email>k.m.dreuning@amsterdamumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joep Derikx, MD, PhD</last_name>
    <phone>+31205665693</phone>
    <email>j.derikx@amsterdamumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Amsterdam UMC, Vrije Universiteit Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J.P.M. Derikx, MD, PhD</last_name>
      <phone>+31205665693</phone>
      <email>j.derikx@amsterdamumc.nl</email>
    </contact>
    <investigator>
      <last_name>J.P.M. Derikx, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emma Children's Hospital, Amsterdam UMC, University of Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J.P.M. Derikx, MD, PhD</last_name>
      <phone>+31205665693</phone>
      <email>j.derikx@amsterdamumc.nl</email>
    </contact>
    <investigator>
      <last_name>J.P.M. Derikx, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Juliana Children's Hospital, HagaZiekenhuis</name>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>G.W. Zijp, MD</last_name>
      <email>g.zijp@hagaziekenhuis.nl</email>
    </contact>
    <investigator>
      <last_name>G.W. Zijp, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R. van Baren, MD</last_name>
      <phone>+31503612306</phone>
      <email>r.van.baren@umcg.nl</email>
    </contact>
    <investigator>
      <last_name>Robertine van Baren, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R.G.J. Visschers, MD, PhD</last_name>
      <phone>+31645296140</phone>
      <email>ruben.visschers@mumc.nl</email>
    </contact>
    <investigator>
      <last_name>R.G.J. Visschers, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erasmus MC - Sophia Children's Hospital</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>H.R. Langeveld, MD, PhD</last_name>
      <email>h.langeveld@erasmusmc.nl</email>
    </contact>
    <investigator>
      <last_name>H.R. Langeveld, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MÃ¡xima Medical Center</name>
      <address>
        <city>Veldhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M.H.M. Bender, MD, PhD</last_name>
      <email>m.bender@mmc.nl</email>
    </contact>
    <investigator>
      <last_name>M.H.M. Bender, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>August 2, 2018</study_first_submitted>
  <study_first_submitted_qc>August 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2018</study_first_posted>
  <last_update_submitted>June 25, 2020</last_update_submitted>
  <last_update_submitted_qc>June 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VU University Medical Center</investigator_affiliation>
    <investigator_full_name>K.M.A. Dreuning</investigator_full_name>
    <investigator_title>Coordinating Investigator HERNIIA trial</investigator_title>
  </responsible_party>
  <keyword>Metachronous contralateral inguinal hernia</keyword>
  <keyword>Hernia repair</keyword>
  <keyword>Contralateral exploration</keyword>
  <keyword>Cost-effectiveness</keyword>
  <keyword>Infants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

